You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • Reference number: TA307
  • Published:  25 March 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix

Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix Colorectal cancer (metastatic) - aflibercept: Appendix D - response to comments on the draft scope and provisional matrix
02 January 2013
(92.91 Kb 27 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 02 January 2013

Back to top